Sarah Sheridan PhD Merck
Sarah Sheridan PhD Merck Technical Consultant
Dr Sarah Sheridan is a Technical Consultant within Merck KGaA, providing scientific, technical and regulatory consultancy on Merck KGaA / BioReliance® Biosafety Testing Services. Drawing on over 22 years of experience in the human and animal health biotech industries, Dr Sheridan provides biosafety testing consultancy for the company’s global client base to support pre-clinical to commercial phase biosafety testing of client manufactured products spanning monoclonal antibodies to vaccines and novel gene therapies. Dr Sheridan has a Ph.D. in Virology from the University of Cambridge, UK and a B.Sc. Honours degree in Life Science.